Systemic antimicrobial treatment

Orthopaedic Knowledge Update: Musculoskeletal Infection

Volumn , Issue , 2018, Pages 117-124

  Marculescu, Camelia E ^a   Osmon, Douglas R ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952513854     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (43)

1. Sia IG, Berbari EF, Karchmer AW: Prosthetic joint infections. Infect Dis Clin North Am 2005;19: 885-914.
2. Osmon DR, Berbari EF: Outpatient intravenous antimicrobial therapy for the practicing orthopaedic surgeon. Clin Orthop Relat Res 2002;403: 80-86.
3. Weed HG: Antimicrobial prophylaxis in the surgical patient. Med Clin North Am 2003;87: 59-75.
4. Shuford JA, Piper KE, Hein M, Trampuz A, Steckelberg JM, Patel R: Lack of association of Staphylococcus aureus type A beta-lactamase with cefazolin combined with antimicrobial spacer placement prosthetic joint infection treatment failure. Diagn Microbiol Infect Dis 2006;54: 189-192.
5. Gilbert DN, Dworkin RJ, Raber SR, Leggett JE: Outpatient parenteral antimicrobial-drug therapy. N Engl J Med 1997;337: 829-838.
6. Mortlock NJ, Schleis T: Outpatient parenteral antimicrobial therapy technology. Infect Dis Clin North Am 1998;12: 861-878.
7. Marculescu CE, Osmon DR: Antibiotic prophylaxis in orthopedic prosthetic surgery. Infect Dis Clin North Am 2005;19: 931-946.
8. Chuard C, Herrmann M, Vaudaux P, Waldvogel FA, Lew DP: Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations. Antimicrob Agents Chemother 1991;35: 2611-2616.
9. Chuard C, Vaudaux P, Waldvogel FA, Lew DP: Susceptibility of staphylococcus aureus growing on fibronectin-coated surfaces to bactericidal antibiotics. Antimicrob Agents Chemother 1993;37: 625-632.
10. Zimmerli W, Trampuz A, Ochsner PE: Prosthetic-joint infections. N Engl J Med 2004;351: 1645-1654.
11. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE: Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: A randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 1998;279: 1537-1541.
12. Zavasky DM, Sande MA: Reconsideration of rifampin: A unique drug for a unique infection. JAMA 1998;279: 1575-1577.
13. Salgado CD, Dash S, Cantey JR, Marculescu CE: Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Clin Orthop Relat Res 2007;461: 48-53.
14. Moise-Broder PA, Sakoulas G, Eliopoulos GM, Schentag JJ, Forrest A, Moellering RC Jr: Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin Infect Dis 2004;38: 1700-1705.
15. Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC Jr, Eliopoulos GM: Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 2004;42: 2398-2402.
16. Rao N, Ziran BH, Hall RA, Santa ER: Successful treatment of chronic bone and joint infections with oral linezolid. Clin Orthop Relat Res 2004;427: 67-71.
17. Rayner CR, Baddour LM, Birmingham MC, Norden C, Meagher AK, Schentag JJ: Linezolid in the treatment of osteomyelitis: Results of compassionate use experience. Infection 2004;32: 8-14.
18. Razonable RR, Osmon DR, Steckelberg JM: Linezolid therapy for orthopedic infections. Mayo Clin Proc 2004;79: 1137-1144.
19. Finney MS, Crank CW, Segreti J: Use of daptomycin to treat drug-resistant gram-positive bone and joint infections. Curr Med Res Opin 2005;21: 1923-1926.
20. Rao N, Regalla DM: Uncertain efficacy of daptomycin for prosthetic joint infections: A prospective case series. Clin Orthop Relat Res 2006;451: 34-37.
21. Yin L-Y, Lazzarini L, Li F, Stevens CM, Calhoun JH: Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model. J Antimicrob Chemother 2005;55: 995-1002.
22. Steckelberg JM, Osmon DR: Prosthetic joint infections, in Bisno AL, Waldvogel FA (eds): Infections of Indwelling Prosthetic Devices. Washington, DC, American Society for Microbiology, 2000, pp 173-209.
23. Berbari EF, Osmon DR, Steckelberg JM: Osteomyelitis and infectious arthritis, in Baddour LM, Gorbach SL (eds): Therapy of Infectious Diseases. Philadelphia, PA, Elsevier, 2003, pp 331-342.
24. Huddleston PM, Steckelberg JM, Hanssen AD, Rouse MS, Bolander ME, Patel R: Ciprofloxacin inhibition of experimental fracture healing. J Bone Joint Surg Am 2000;82: 161-173.
25. Lew DP, Waldvogel FA: Quinolones and osteomyelitis: State-of-the-art. Drugs 1995;49(suppl 2): 100-111.
26. Mader JT, Calhoun JC, Lazzarini L: Adult long bone osteomyelitis, in Calhoun JS, Mader JT (eds): Musculoskeletal Infections. New York, NY, Marcel Dekker, 2003, pp 149-177.
27. Calhoun JH, Manring MM: Adult osteomyelitis. Infect Dis Clin North Am 2005;19: 765-786.
28. Goldenberg DL: Septic arthritis. Lancet 1998;351: 197-202.
29. Haas DW, McAndrew MP: Bacterial osteomyelitis in adults: Evolving considerations in diagnosis and treatment. Am J Med 1996;101: 550-561.
30. Lew DP, Waldvogel FA: Osteomyelitis. N Engl J Med 1997;336: 999-1007.
31. Lipski BA, Berendt AR, Deery HG, et al: Diagnosis and treatment of diabetic foot infections. Plast Reconstr Surg 2006;117: 212-238.
32. Mader JT, Shirtliff ME, Bergquist SC, Calhoun J: Antimicrobial treatment of chronic osteomyelitis. Clin Orthop Relat Res 1999;360: 47-65.
33. Ross JJ: Septic arthritis. Infect Dis Clin North Am 2005;19: 799-817.
34. Hoffman-Terry ML, Fraimow HS, Fox TR, Swift BG, Wolf JE: Adverse effects of outpatient parenteral antibiotic therapy. Am J Med 1999;106: 44-49.
35. Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A: High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: Efficacy and toxicity. Arch Intern Med 2006;166: 2138-2144.
36. Tice AD, Rehm SJ, Dalovisio JR, et al: Practice guidelines for outpatient parenteral antimicrobial therapy: IDSA guidelines. Clin Infect Dis 2004;38: 1651-1672.
37. Brandt CM, Sistrunk WW, Duffy MC, et al: Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 1997;24: 914-919.
38. Rao N, Crossett LS, Sinha RK, Le Frock JL: Long-term suppression of infection in total joint arthroplasty. Clin Orthop Relat Res 2003;414: 55-60.
39. Segreti J, Nelson JA, Trenholme GM: Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin Infect Dis 1998;27: 711-713.
40. Tsukayama DT, Wicklund B, Gustilo RB: Suppressive antibiotic therapy in chronic prosthetic joint infections. Orthopedics 1991;14: 841-844.
41. Kowalski TJ, Berbari EF, Huddleston PM, Steckelberg JM, Mandrekar JN, Osmon DR: The management and outcome of spinal implant infections: Contemporary retrospective cohort study. Clin Infect Dis 2007;44: 913-920.
42. Goulet JA, Pellicci PM, Brause BD, Salvati EM: Prolonged suppression of infection in total hip arthroplasty. J Arthroplasty 1988;3: 109-116.
43. Marculescu CE, Berbari EF, Hanssen AD, et al: Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 2006;42: 471-478.